Andreas Verstraete

First Belgian experience with large-bore mechanical thrombectomy in acute pulmonary embolism using the FlowTriever ® system: a bi-centre retrospective analysis

Sébastien Selleslag, Jesse Marrannes, Lawrence Bonne, Andries Van Holsbeeck et autres

Background Pulmonary embolism (PE) is a major cause of cardiovascular morbidity and mortality. Large-bore mechanical thrombectomy (LBMT) is an emerging treatment for high-risk and intermediate-high-risk PE, particularly in patients with contraindications to thrombolysis. We evaluated the safety, efficacy, and clinical outcomes of …

be, cy (code pays fourni par la source)

Direct oral anticoagulant use and drug–drug interactions in transplant recipients receiving calcineurin inhibitors

Andreas Verstraete, Erwin Dreesen, Quentin Van Thillo, Margot Erard et autres

be (code pays fourni par la source)

Venous thromboembolism in women on estrogen therapy: presentation, management, and outcomes in the RIETE registry

Andreas Verstraete, Thomas Vanassche, Angeles Blanco-Molina, Juan Criado-García et autres

ABSTRACT: Combined oral contraceptives increase the venous thromboembolism (VTE) risk nearly fivefold. Their widespread use translates into a substantial number of VTE events in otherwise healthy young women. However, data on estrogen-associated VTE remain limited. We used data from the RIETE registry …

be, es, ec, fr, nl (code pays fourni par la source)

Management of high-risk acute pulmonary embolism

Andrea Stadlbauer, Tom Verbelen, Leonhard Binzenhöfer, Tomaž Goslar et autres

de, be, si (code pays fourni par la source)

Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestry

Art Schuermans, Andreas Verstraete, Vilma Lammi, Tomoko Nakanishi et autres

us, be, fi, jp, ca, gb, de, se (code pays fourni par la source)

Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestry.

Art Schuermans, Andreas Verstraete, Vilma Lammi, Tomoko Nakanishi et autres

Epidemiology of Venous Thromboembolism in Belgium: A Cohort Study

Andreas Verstraete, Nicholas Cauwenberghs, Shayan Calhori, Kathleen Freson et autres

Abstract Venous thromboembolism (VTE) is a significant contributor to global morbidity and mortality. Although management strategies and the distribution of risk factors have evolved, contemporary epidemiologic data are limited and have not been previously reported for Belgium. We aimed to characterize the …

be (code pays fourni par la source)

New horizons in the pharmacological management of venous thromboembolism

Andreas Verstraete, Quentin Van Thillo, Thomas Vanassche, Peter Verhamme

Many patients suffer from venous thromboembolism (VTE) and its consequences. Despite substantial advancements with the introduction of direct oral anticoagulants (DOACs), patients and clinicians still encounter challenges in the acute and long-term management of VTE, such as recurrent events, anticoagulant-related bleeding complications, …

be (code pays fourni par la source)

Genotype vs laboratory phenotype correlation of defects in natural anticoagulants in patients with venous thromboembolism

Christine Van Laer, Marthe Vanrenterghem, Marc Jacquemin, Andreas Verstraete et autres

be, nl (code pays fourni par la source)

Implementation and clinical utility of multigene panels for bleeding, platelet, and thrombotic disorders

Radha Ramanan, Andreas Verstraete, Christine Van Laer, Kathleen Freson

au, be (code pays fourni par la source)

Acute and long-term outcomes of patients with high-risk pulmonary embolism treated with advanced therapies

Andreas Verstraete, Pascal Frederiks, Lorenz Van der Linden, Tom Verbelen et autres

While most pulmonary embolism (PE) cases present with mild to moderate severity and low mortality risk, 1–3% develop haemodynamic instability, requiring intensive care and advanced therapies such as thrombolysis, thrombectomy, and/or veno-arterial extracorporeal membrane oxygenation (VA-ECMO).1 High-risk PE encompasses a spectrum ranging …

be (code pays fourni par la source)

Management of high-risk acute pulmonary embolism: an emulated target trial analysis

Andrea Stadlbauer, Tom Verbelen, Leonhard Binzenhöfer, Tomaž Goslar et autres

BACKGROUND: High-risk acute pulmonary embolism (PE) is a life-threatening condition necessitating hemodynamic stabilization and rapid restoration of pulmonary perfusion. In this context, evidence regarding the benefit of advanced circulatory support and pulmonary recanalization strategies is still limited. METHODS: In this observational study, …

de, be, si, es, it, at, pt, lv, fr (code pays fourni par la source)